COMMUNIQUÉS West-GlobeNewswire

-
ChromaDex Furthers TRU NIAGEN® Global Expansion in Canada with WELL Health Technologies
24/04/2019 -
Integra LifeSciences Reports First Quarter 2019 Financial Results
24/04/2019 -
Amarin To Report First Quarter 2019 Results and Host Conference Call On May 1, 2019
24/04/2019 -
Professor Paul Fitzgerald joins Nexstim's Scientific Advisory Board
24/04/2019 -
CellaVision AB presents the first quarter for 2019 on May 7 at 11:00 CET
24/04/2019 -
Interim report for the first 3 months of 2019
24/04/2019 -
Oxurion NV announces full enrollment in its Phase 1 trial evaluating the safety of its plasma kallikrein inhibitor THR-149 for treatment of DME, ahead of schedule
24/04/2019 -
Novartis starts 2019 with strong sales and double digit core[1] operating income growth, Mayzent launch and Alcon spin-off; profit guidance upgraded
24/04/2019 -
Novartis entame 2019 avec une forte croissance des ventes et une hausse à deux chiffres du résultat opérationnel core[1], le lancement de Mayzent et le spin-off d'Alcon; profit annuel revu à la hausse
24/04/2019 -
MDxHealth (R): MDxHealth provides Q1 2019 business update
24/04/2019 -
MDxHealth (R) : MDxHealth publie son rapport d'activité du T1 2019
24/04/2019 -
Number of shares and voting rights of Innate Pharma as at April 18, 2019
24/04/2019 -
Nouveau nombre d’actions et de droits de vote d’Innate Pharma au 18 avril 2019
24/04/2019 -
Pixium Vision and research partners to report clinical progress with the PRIMA bionic vision system during ARVO 2019 World Conference
24/04/2019 -
Pixium Vision et ses partenaires de recherche présenteront les progrès cliniques du système vision bionique PRIMA lors du congrès mondial de l’ARVO 2019
24/04/2019 -
China FDA Approval for Oscar 2 Blood Pressure Monitor with CardieX’s "SphygmoCor® Inside" Technology
24/04/2019 -
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Glioblastoma
24/04/2019 -
Psychemedics Announces First Quarter Results and Declares 91st Consecutive Quarterly Dividend
23/04/2019 -
Harvard Bioscience Schedules First Quarter 2019 Conference Call for May 2 at 4:30 PM ET
23/04/2019
Pages